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Comparison of the Promoting Effects of
Various Agents in Induction of
Preneoplastic Lesions in Rat Liver
by Nobuyuki Ito,* Hiroyuki Tsuda,* Ryohei Hasegawa*
and Katsumi Imaida*
The promoting activities of 29 compounds on induction of hyperplastic (neoplastic) liver nodules
(HN) and the dose-dependent effects of tumor promoting agents were compared by using a short-
term test system developed in this laboratory.
In tests on promoting activity, F344 rats were given a single dose (200 mg/kg) ofN-nitrosodiethyl-
amine (DEN), and from two weeks later, were treated with various test compounds for 6 or 10 weeks.
They were subjected to partial hepatectomy 3 or 4 weeks after DEN treatment. The results showed
that strong hepatocarcinogens, such as aflatoxin B1, DEN, N-nitrosodimethylamine (DMN), 2-acetyl-
aminofluorene (2-AAF), 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB) and ethionine, induced
many hyperplastic liver nodules, whereas dieldrin, 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane
(DDT), polychlorinated biphenyls (PCB) and a-hexachlorocyclohexane (a-HCH) induced few lesions.
Nonhepatocarcinogens, such as N-nitrosoethylurea (ENU) and 3-methylcholanthrene (3-MC), only
slightly induced hyperplastic nodules. Of the miscellaneous compounds tested, phenobarbital, deox-
ycholic acid and ethynyl estradiol also induced y-glutamyl transpeptidase (y-GT) positive foci.
In tests on the dose-dependent effects of promoting agents, DMN was given at different concentra-
tions for 6 weeks from 2 weeks after DEN treatment. Results were quantitated by histochemical
measurement of the number or area of y-GT positive lesions induced. A long-term experiment on the
effect of feeding DMN for 96 weeks was also done. Clear dose-dependent effects of DMN were seen in
induction of y-GT positive foci in the short-term experiment and neoplastic lesions in the long-term
one.
Introduction
Since the proposal of a two-stage process of
chemical carcinogenesis in mouse skin, extensive in-
vestigations have been carried out to understand
the mechanism of the initiation-promotion process
(1). Initiation is thought to introduce neoplastic in-
formation into the cells, possibly by some alteration
of cellular DNA, whereas treatment with a pro-
moter given continuously over a relatively long per-
iod is thought to allow phenotypic expression of the
altered genome eventually leading to neoplastic
growth. This two-stage process of carcinogenesis
was also demonstrated more recently in liver carci-
nogenesis with 2-acetylaminofluorene (2-AAF) as an
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initiator and phenobarbital as a promoter (2,3). A
similar two-stage mechanism has been proposed for
carcinogenesis in urinary bladder (4-6), mammary
gland (7), thyroid gland (8) and intestines (9).
The actual risk to humans of chemicals in the
environment is usually the result of multiple ex-
posures to a wide variety of agents, including car-
cinogens and promoters, and there is increasing evi-
dence that these compound infact contribute to the
induction of human cancer. However, it is difficult
to test all possible factors in long-term in vivo ex-
periments, and no suitable in vitro short-term test
for promoting agents has yet been reported. Thus a
short-term in vivo assay for promoting agents is ur-
gently needed. Previous studies on this problem in
this laboratory indicated that when rats were pre-
treated with N-nitrosodiethylamine (DEN) and then
exposed to various promoting agents for 6 to 10
weeks, quantitatively detectable numbers of hyper-ITO ETAL.
plastic (neoplastic) nodules (HN) were formed in
their liver (10). The HN measured in this experi-
ment included hyperplastic foci (areas of cellular al-
terations) and hyperplastic nodules (neoplastic nod-
ules) of more than 0.2 mm diameter, as previously
described (10). The aims of this study were to oW
serve the sequence in which hepatocellular carcino-
mas develop from early preneoplastic lesions and to
define HN; to study the dose-dependent effects in
long-term experiments for carcinogenicity and in
short-term tests for promoting activity on the inci-
dence of neoplastic and preneoplastic lesions, and to
compare the activities of various compounds as pro-
moters of preneoplastic liver lesions in the short-
term model system.
Hyperplastic (Neoplastic) Nodules
in the Liver of Rats Treated with
DEN followed by 2-AAF or a-HCH
The behavior and fate of hyperplastic nodules
(HN) induced in an in vivo short-term screening test
for hepatocarcinogens were studied (11). Fischer 344
rats were injected intraperitoneally with DEN (200
mg/kg body weight) and fed basal diet for first 2
weeks, followed by basal diet containing 2-AAF (200
ppm) or a-hexachlorocyclohexane (a-HCH) (1000
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ppm) for 6 weeks and again placed on basal diet un-
til week 50. Two-thirds partial hepatectomy was
performed at the end of week 3. Animals were
killed in week 4, 6, 8, 10, 20, 30, 40 or 50 of the ex-
periment.
The numbers and areas of HN per unit area in
microscopic sections of liver are shown in Figures 1
and 2, respectively. In the liver of rats treated with
2-AAF, the number and'area of HN were maximal
in week 10, and then gradually decreased to week
50 (p<0.001). However, the area remained almost
constant from week 30 to 50. In the group given a-
HCH, the number and area of HN gradually in-
creased throughout the experiment. The decrease
of HN in 2-AAF treated rats after week 10 was ap-
parently due to their degeneration or disappear-
ance. Therefore, the numbers and areas of degener-
ated or necrotic nodules which had a spongy or cys-
tic appearance were also measured. The histological
features of the lesions, which were diagnosed as de-
generated hyperplastic nodules (DHN), were similar
to those seen in spongiosis hepatis reported by Ban-
nasch et al. (12). The number and area (not shown) of
these degenerated hyperplastic nodules (DHN) in-
creased with time until week 30 and then decreased
or remained almost constant in rats given 2-AAF or
a-HCH (Fig. 3). The maximal number of hepatocellu-
lar carcinoma was reached at week 40 (Fig. 4).
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FIGURE 1. Sequential changes in the number of hyperplastic (neoplastic) nodules (HN).
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FIGURE 2. Sequential changes in the area of hyperplastic (neoplastic) nodules (HN).
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FIGURE 3. Sequential changes in the number of degenerated hyperplastic nodules (DHN).
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FIGURE 4. Sequential changes in the number of hepatocellular carcinomas (HCC).
This experiment shows that detectable preneo-
plastic lesions in the liver, measured as HN, were
induced in DEN-treated rats by exposure to pro-
moting agents for 6 weeks in combination with par-
tial hepatectomy. Their number and area started to
decrease 2 weeks after the end of exposure to pro-
moting agents (10 weeks after DEN) due to degen-
erative change.
Dose-Dependent Effects of DEN in
Induction of Preneoplastic Lesions
of Rat Liver
N-Nitrosodimethylamine (DMN) was given at con-
centrations of 10.0, 1.0 and 0.1 ppm in the diet for 6
weeks after initiation with DEN to test its dose-de-
pendent effect in promotion (Fig. 5). In this experi-
ment, the number and area of preneoplastic liver le-
sions giving a positive reaction for y-glutamyltrans-
peptidase (y-GT) were measured (13). A long-term
experiment in which DMN was given continuously
in the diet for 96 weeks at the same concentrations
as in the short-term test (10.0, 1.0 and 0.1 ppm) was
also carried out to examine whether the incidence
of y-GT positive foci in the short-term experiment
was comparable to that of HN in the long-term ex-
periment. A significant dose-dependent response in
0 2 3 8 Wks.
DEN PH
0.9% NaCI PH
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Dimethyinitrosamine in diet
Basal diet
FIGURE 5. Experimental design of short-term test for pro-
moting activity as determined by an enhancement of hy-
perplastic (neoplastic) nodules or y-GT positive foci.
the induction of y-GT positive foci in the short-term
test and also HN or malignant neoplasias in the
long-term test were shown among the higher range
of doses (14). In these experiments the results of the
short-term experiment clearly reflected those of the
long-term one (Tables 1 and 2). Similarly, a clear
dose-dependent effect on the enhancement of HN in-
duction was seen with different doses of phenobar-
bital (15,16). Since most y-GT positive cell foci devel-
op into HN (17), this system for detecting preneo-
plastic changes seems suitable for analytical studies
on promoters or factors that enhance chemical carci-
nogenesis.
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Table 1. Dose-dependent effect of short-term treatment withN-nitrosodimethylamine (DMN) in induction of y-glutamyl transpeptidase
(y-GT) positive foci in rats after initiation byN-nitrosodiethylamine (DEN).
Treatment Dose of No. of y-GT positive foci in liver
with DEN DMN, ppm animals No./cm2 Area, mm2/cm2
+ 10.0 20 10.3 ± 2.9* 0.30 ± 0.1*
+ 1.0 20 6.1± 1.6* 0.23± 0.1
+ 0.1 19 4.1 ± 1.1 0.14 ± 0.1
+ 0 21 4.0± 1.1 0.14 ±0.1
10.0 17 <0.2 <0.01
* Significantly different from other groups.
Table 2. Dose-dependent effect in induction of liver tumors in rats treated withN-nitrosodimethylamine (DMN) for 96 weeks.
Changes in liver, %
Dose of No. of Hyperplastic Hepatocellular Hemangio- Fibro-
DMN, ppm rats nodule carcinoma endothelioma sarcoma
10.0 17 6 (35)* 1 (6) 3 (18)* 5 (29)*
1.0 15 1 ( 1) 1 (7) 0 - 1 ( 7)
0.1 9 0 - 0 - 0 - 0 -
0 7 0 - 0- 0 - 0 -
* Significantly different from other groups.
Table 3. Quantitation of hyperplastic (neoplastic) nodules induced by test compounds in rat liver after initiation by
N-nitrosodiethylamine (DEN).
Hyperplastic (neoplastic) nodulesb
Dose, No./cm2 Area, mm2/cm2
Compound ppm Routea DEN Saline DEN Saline
Chlorobenzilate 3000 D 3.3 ± 1.2* (18) 0 ( 8) 1.0 ± 0.4* 0
Ethionine 2500 D 3.4 ± 1.3* (13) 0 (10) 1.0 ± 0.4* <0.1
Quinoline 2500 D 1.2± 0.6 (14) 0 ( 9) 0.3± 0.2* 0
Thioacetamide 1000 D 10.8 ± 4.2* (12) 0.6 ± 0.4 ( 9) 6.6 ± 3.0* 0.1 ± 0.1
a-HCH 1000 D 3.3 ± 1.4* (12) 0 ( 8) 2.0 ± 0.8* 0
PCB 1000 D 1.4± 0.6 (12) 0 ( 8) 0.5±0.3* 0
3'-Me-DAB 600 D 15.9+ 4.8* (17) 1.9 ± 1.1 ( 9) 10.9 ± 5.5* 0.5±+0.3
DDT 500 D 3.6± 1.3* (13) 0 ( 8) 1.2±0.5* 0
2-AAF 200 D 24.3 ± 7.6* (14) 10.0 ± 5.0 ( 9) 17.1 ± 5.4* 4.3 ± 3.6
Sterigmatocystin 120 D 7.8 ± 3.5* (13) 0.1 ± 0.2 ( 9) 3.7 ± 1.9* <0.1
DEN 100 W 28.7± 16.1* (17) 16.7± 7.4 (10) 17.2± 9.6* 3.6± 2.9
DMN 100 D 9.5 ± 2.1* (17) 0.2 ± 0.3 ( 9) 5.7 ± 1.3* <0.1
Dieldrin 100 D 2.7± 0.1* (13) 0 ( 8) 0.8±0.4* 0
Hexachlorobenzene 50 D 3.2 ± 1.7* (21) 0 (10) 0.7 ± 0.4* 0
Aldrin 50 D 2.5± 1.3* (18) 0 ( 8) 0.5± 0.3* 0
Aflatoxin B1 2 D 31.6 ± 7.4* (12) 3.5 ± 1.0 ( 9) 10.3 ± 5.5* 1.0 0.3
Control - - 1.5± 1.2 (34) - 0
a Route: D = in diet; W = in drinking water.
b Numbers in parentheses denote numbers of animals.
* Significantly different from control.
Effects of Exogenous and
Endogenous Promoting Agents on
Induction of Preneoplastic Lesions
In tests on the promoting activities of various
compounds, rats were injected intraperitoneally
with DEN or saline (control), given test compounds
by an appropriate route for 6 weeks and then killed
(Fig. 5). One week after the start of treatment with
test compounds, a two-thirds partial hepatectomy
was performed to stimulate cell proliferation (18).
The doses and routes of administration of test com-
pounds are shown in Tables 3-6. In tests on hor-
mones and bile acids, a modified experimental sche-
dule was used: test compounds were given for 10
weeks and partial hepatectomy was performed in
week 4 (Fig. 5). Doses of chemicals were chosen on
the basis of their LD. values (19).
Results show that administration of strong hepa-
tocarcinogens, such as aflatoxin B1, DEN, DMN, 2-
AAF, 3'-methyl4-dimethylaminoazobenzene (3/-Me-Table 4. Quantitation of hyperplastic (neoplastic) nodules induced by test compounds in rat liver after initiation by
N-nitrosodiethylamine (DEN).
Hyperplastic (neoplastic) nodulesc
Dose, No./cm2 Area, mm2/cm2
Compounda ppm Routeb DEN Saline DEN Saline
BBN 1800 W 2.0 ± 1.4 (14) 0 (10) 0.2 ± 0.2 0
ENNG 20 mgx7 P 1.1±0.9 (15) - 0.1±0.1 0
MNNG 400 W 1.6± 0.7 (15) 9 ( 9) 0.2± 0.1 0
ENU 300 W 2.5± 1.1* (14) 0 (10) 0.4± 0.1* 0
BNU 20 mg x 7 P 1.2 ± 1.2 (12) - 0.1 ± 0.1 0
3-MC 100 D 1.7 ± 1.0* (14) 0 (10) 0.7 ± 0.2* 0
7,12-DMBA 30 mg x 7 G 1.1 ± 1.1 (11) - 0.1 ± 0.1 0
B(a)P 30 mg x 7 G 1.0 ± 0.6 (12) - 0.1 ± 0.1 0
Amitrole 15000 D 3.6± 2.4* (15) - 0.8± 0.7* 0
Control - - 1.5± 1.2 (34) - 0 -
a Compounds: BBN, N-butyl-N-(4-hydroxybutyl)nitrosamine; ENNG, N-ethyl-N'-nitro-N-nitrosoguanidine; MNNG, N-methyl-N'-
nitro-N-nitrosoguanidine; ENU, N-ethylnitrosourea; BNU, N-nitrosobutylurea, 7,12-DMBA, 7,12-dimethylbenz(a)anthracene; B(a)P,
benzo(a)pyrene.
b Route: W = in drinking water; P = intraperitoneal injection; D = in diet; G = intragastric feeding.
Numbers in parentheses denote numbers of animals.
* Significantly different from control.
Table 5. Quantitation of hyperplastic (neoplastic) nodules induced by test compounds in rat liver after initiation by
N-nitrosodiethylamine (DEN).
Hyperplastic (neoplastic) nodulesb
Dose, No./cm2 Area, mm2/cm2
Compound ppm Routea DEN Saline DEN Saline
Quercetin 50000 D 1.7± 0.8 (12) 0 (10) 0.3+ 0.3 0
Caffeine 1000 W 1.6± 1.0 (20) 0 (10) 0.2+ 0.1 0
BHT 1000 D 1.0 ± 1.2 (14) 0 ( 9) 0.1± 0.1 0
Endrin 25 D 1.8+ 0.8 (16) 0 ( 8) 0.3± 0.2 0
Saccharin 50000 D 1.4± 1.3 (18) 0 (10) 0.2± 0.1 0
Phenobarbital 500 D 3.1 + 2.3* (15) 0 (10) 1.0 ± 0.7 0
Control - - 1.5± 1.2 (34) - 0 -
' Route: D = in diet; W = in drinking water.
b Numbers in parentheses denote numbers of animals.
* Significantly different from control.
Table 6. Quantitation of y-glutamyl transpeptidase-positive foci induced by test compounds in the rat liver after initiation by
N-nitrosodiethylamine (DEN).
y-GT positive focib
Dose, No./cm2 Area, mm2/cm2
Compound ppm Routea DEN Saline DEN Saline
Ethynyl estradiol 10 D 7.8± 2.1* (14) 0 (12) 1.5± 1.5* 0
Dexamethasone 0.5 D 5.6± 1.8* (11) 0 (13) 0.2± 0.1* 0
Testosterone 500 D 5.3± 1.3* (15) 0 (14) 0.2± 0.1* 0
Cortisone 10 D 3.8± 1.5* (15) 0 (12) 0.2± 0.1 0
Deoxycholic acid 5000 D 23.8 ± 9.8* (14) 0.5 ± 0.5 ( 7) 12.7 ± 11.2* 0.1 ± 0.1
Taurine 5000 D 3.9 1.4* (12) 0 (15) 0.1± 0.0 0
Lithocholic acid 5000 D 3.5 1.1* (14) 0 (15) 0.3± 1.1 0
Phenobarbital 500 D 14.4 2.6* (11) 0 (10) 1.3± 0.5 0
Control - D 2.2± 0.9 (19) - ( ) 0.1 ± 0.1 -
a Route: D = in diet.
b Numbers in parentheses denote numbers of animals.
* Significantly different from control.
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DAB), thioacetamide, sterigmatocystin and ethio-
nine, resulted in large numbers of HN, whereas diel-
drin, DDT, polychorinated biphenyls (PCB) and a-
HCH had less promoting activity. Nonhepatocarcin-
ogens, such as N-ethylnitroso urea (ENU), 3-methyl-
cholanthrene (3-MO) and aminotriazole (amitrole)
also caused slight induction of HN. Of the miscella-
neous compounds tested, only phenobarbital caused
appreciable HN induction (Tables 3-5).
Among the hormones and bile acids tested by the
modified schedule, ethynyl estradiol, dexametha-
sone, testosterone and deoxycholic acid greatly in-
creased both the number and area of y-GT positive
foci (Table 6). In this experiment, y-GT positive foci
were measured quantitatively becasue they appear
earlier than HN and therefore their measurement is
more sensitive than that of HN.
Hepatocarcinogens and chemicals with promoting
activity in liver carcinogenesis gave positive results
in this system. Liver carcinogens had strong pro-
moting effects, and some nonliver carcinogens had
weak promoting effects. Thus our system could be
used for screening for hepatocarcinogens or pro-
moters of hepatocarcinogenesis as epigenetic fac-
tors and also for estimating their potency.
Conclusions
The present work shows that detectable preneo-
plastic lesions are induced by short-term exposure
(6-10 weeks) to promoting agents in rats initiated
by DEN. Their promoting effect of DMN is dose-de-
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FIGURE 6. Diagrammatic representation of probable relation-
ships between neoplastic growth and modifying factors.
The vertical axis shows different stages of neoplastic de-
velopment and the horizontal axis shows the time. The
effect of promoter is thought to shorten the period of early
or preneoplastic stage by increasing the angle of aslant
lines, with eventual earlier development of cancer before
completing life span.
pendent in both short- and long-term tests. There
was a good correlation between quantitative values
for early preneoplastic lesions (y-GT positive foci)
and the incidences of the more advanced lesions,
such as of hyperplastic (neoplastic) nodules and he-
patocellular carcinomas.
Strong liver carcinogens were shown to have
strong promoting effects. Thus various tumor pro-
moting agents can be detected and their potencies
can be measured with the system developed in this
study. Figure 6 shows diagrammatically possible re-
lationships between different neoplastic stages and
their modifying factors. When the initiation is
strong and proliferation of initiated cells is rapid,
the patient will die of cancer before completing life-
span. However, when the proliferation is slow, the
lifespan is completed before cancer develops; in
other words, the patient does not die of cancer. The
effect of promoter is thought to shorten the period
of early or preneoplastic stage by increasing the
angle of aslant lines in the diagram. If we could de-
tect some compound with an effect to decrease this
angle, the compound would be used as an antipro-
moter.
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